Insiders Altimmune, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			Pre-market 09:01:54 am
6.455 ^USD	-4.09%		6.5	+0.70%

Jun. 05	Altimmune, Inc. Presents Data at EASL International Liver Congress?? 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis	CI
May. 23	Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM

Altimmune, Inc. Appoints Catherine Angell Sohn, Pharm.D. to Its Board of Directors	23-03-27	CI
Altimmune, Inc. Appoints Raymond Jordt as Chief Business Officer	23-01-04	CI
Insider Sell: Altimmune	22-12-22	MT
Insider Sell: Altimmune	22-09-01	MT
Insider Sell: Altimmune	22-07-05	MT
Insider Sell: Altimmune	22-06-28	MT
Altimmune, Inc. Announces Management Changes	21-12-13	CI
Altimmune Names Richard Eisenstadt as Next CFO	21-12-13	MT
ObsEva Names Will Brown Chief Financial Officer	21-12-13	MT
ObsEva to Appoint Altimmune CFO to Same Position	21-12-13	MT
Insider Trends: Altimmune Insider Disposition Interrupting 90-Day Buy Trend	20-12-02	MT
Insider Trends: 90-Day Insider Buying Trend at Altimmune Interrupted with Disposition of Shares	20-11-13	MT
Insider Trends: Insider Disposition at Altimmune Scaling Back 90-Days of Buying	20-11-13	MT
Altimmune, Inc. Announces Board Changes	20-07-16	CI
Altimmune, Inc. Appoints Diane Jorkasky to Its Board of Directors	20-05-12	CI
Altimmune, Inc. Appoints M. Scott Harris as Chief Medical Officer	19-09-09	CI
Altimmune, Inc. Announces Appointment of William Brown as Chief Financial Officer	19-06-12	CI
Altimmune, Inc. Announces Resignation of Sybil Tasker as Chief Medical Officer, Effective June 30, 2019	19-06-07	CI
Altimmune, Inc. Announces Executive Changes	18-11-27	CI
Altimmune, Inc. Announces Management Changes	18-10-22	CI

No results for this search